cifenline has been researched along with Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, M | 1 |
| Okayama, H | 1 |
| Yoshii, T | 1 |
| Hiasa, G | 1 |
| Sumimoto, T | 1 |
| Inaba, S | 1 |
| Nishimura, K | 1 |
| Inoue, K | 1 |
| Ogimoto, A | 1 |
| Shigematsu, Y | 1 |
| Funada, J | 1 |
| Hamada, M | 1 |
| Higaki, J | 1 |
1 other study available for cifenline and Cirrhosis
| Article | Year |
|---|---|
Myocardial fibrosis attenuates the effect of cibenzoline on left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
Topics: Cardiomyopathy, Hypertrophic; Diastole; Female; Fibrosis; Humans; Imidazoles; Male; Middle Aged; Myo | 2011 |